World Tuberculosis Day 2014 The TB situation in

  • Slides: 20
Download presentation
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB

World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office for Europe ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March 2014

TB notifications by country In 2012, 68 423 TB cases were reported in the

TB notifications by country In 2012, 68 423 TB cases were reported in the EU/EEA. The notification rate was 13. 5 per 100 000 population (range 3. 4– 85. 2). Figure 1: TB notification rate per 100 000 population by country, EU/EEA, 2012 < 10 per 100 000 10 to 19 per 100 000 20 to 49 per 100 000 50 to 99 per 100 000 Not included or not reporting 2

EU definition: Confirmed TB cases* Overall, 61. 9% (range 21. 5– 91. 4%) of

EU definition: Confirmed TB cases* Overall, 61. 9% (range 21. 5– 91. 4%) of TB cases reported in the EU/EEA were laboratory confirmed. Figure 2: Percentage of laboratoryconfirmed TB cases by country, EU/EEA, 2012 < 60% 60 to 69% 70 to 79% ≥ 80% Not included or not reporting * Confirmed by culture or by both a positive sputum microscopy result and Mycobacterium tuberculosis nucleic acid identified in nucleic acid amplification test. 3

TB in children In 2012, 2 845 TB cases in children were reported, accounting

TB in children In 2012, 2 845 TB cases in children were reported, accounting for 4. 2% of all notified TB cases (range 0– 7. 8%) in the EU/EEA. Figure 3: TB notification rate in children under 15 years of age per 100 000 child population, by country, EU/EEA, 2012 < 2 per 100 000 child population 2 to 3. 9 per 100 000 child population 4 to 9. 9 per 100 000 child population ≥ 10 per 100 000 child population Not included or not reporting 4

TB cases of foreign origin In 2012, the overall proportion of TB cases of

TB cases of foreign origin In 2012, the overall proportion of TB cases of foreign origin in the EU/EEA was 26. 8% (range 0. 2– 85. 4%). Figure 4: Percentage of TB cases of foreign origin by country, EU/EEA, 2012 < 1% 1 to 24. 9% 25 to 49. 9% 50 to 74. 9% ≥ 75% Not included or not reporting 5

Extrapulmonary TB cases In 2012, the overall proportion of extrapulmonary TB cases in the

Extrapulmonary TB cases In 2012, the overall proportion of extrapulmonary TB cases in the EU/EEA was 23. 0% (range 2. 9– 48. 6%). Figure 5: Percentage of extrapulmonary TB cases by country, EU/EEA, 2012 < 10% 10 to 19. 9% 20 to 29. 9% 30 to 39. 9% ≥ 40% Not included or not reporting 6

Extrapulmonary TB notification over time Extrapulmonary TB notification rates have remained stable in the

Extrapulmonary TB notification over time Extrapulmonary TB notification rates have remained stable in the last 10 years. Figure 6: Extrapulmonary TB notification rate per 100 000 population by year, EU/EEA, 2003− 2012 Notification rate per 100 000 population 4 3 2 1 0 2003 2004 2005 2006 2007 2008 Year of reporting 2009 2010 2011 2012 7

Multidrug-resistant TB In 2012, the overall proportion of TB cases with multi-drug resistance in

Multidrug-resistant TB In 2012, the overall proportion of TB cases with multi-drug resistance in the EU/EEA was 4. 6% (range 0– 25. 5%). Figure 7: Percentage of multidrug resistance among all confirmed TB cases by country, EU/EEA, 2012 < 1% 1 to 1. 9% 2 to 4. 9% 5 to 9. 9% ≥ 10% Not included or not reporting 8

Multidrug-resistance among new pulmonary TB cases In 2012, the overall percentage of new pulmonary

Multidrug-resistance among new pulmonary TB cases In 2012, the overall percentage of new pulmonary TB cases with multidrug resistance in the EU/EEA was 2. 6% (range 0 – 20. 5%). Figure 8: Percentage of new pulmonary TB cases with multidrug resistance by country, EU/EEA, 2012 < 1% 1 to 1. 9% 2 to 4. 9% ≥ 5% Not included or not reporting 9

Multidrug-resistance among previously treated pulmonary TB cases In 2012, the overall proportion of previously

Multidrug-resistance among previously treated pulmonary TB cases In 2012, the overall proportion of previously treated pulmonary TB cases with multidrug resistance in the EU/EEA was 18. 8% (range 0– 50. 0%). Figure 9: Percentage of previously treated pulmonary TB cases with multidrug resistance by country, EU/EEA, 2012 < 1% 1 to 9. 9% 10 to 19. 9% ≥ 20% Not included or not reporting 10

Extensively drug-resistant TB In 2012, the proportion of extensively drug-resistant TB cases among multidrug-resistant

Extensively drug-resistant TB In 2012, the proportion of extensively drug-resistant TB cases among multidrug-resistant cases in EU/EEA was 13. 7% (range 0– 50. 0%). Figure 10: Percentage of extensively drug-resistant TB cases among multidrugresistant TB cases tested for second-line drug susceptibility, by country, EU/EEA, 2012 < 1% 1 to 9. 9% 10 to 19. 9% ≥ 20% Not included or not reporting 11

TB/HIV co-infection In 2012, the overall proportion HIV positive among TB cases with known

TB/HIV co-infection In 2012, the overall proportion HIV positive among TB cases with known HIV status in EU/EEA was 5. 5% (range 0– 16. 5%). Figure 11: Percentage of HIVpositive cases among TB cases with known HIV status, by country, EU/EEA, 2012 < 1% 2 to 4. 9% 5 to 9. 9% ≥ 10% Not included or not reporting 12

Treatment success in new pulmonary TB cases over time The treatment success rate in

Treatment success in new pulmonary TB cases over time The treatment success rate in new culture-confirmed pulmonary TB cases notified between 2007 and 2011 has slightly decreased from 79. 2% in 2007 to 76. 5% in 2011. Figure 12: 12 -month treatment success rate in new cultureconfirmed pulmonary TB cases by year of initial case reporting, EU/EEA, 2007– 2011 Treatment success (%) 100 80 60 40 20 0 6/29/1905 12: 00 AM Year of initial reporting 13

Treatment success in new pulmonary TB cases Treatment success rate for culture-confirmed new pulmonary

Treatment success in new pulmonary TB cases Treatment success rate for culture-confirmed new pulmonary TB cases notified in 2011 was 76. 5% (range: 0– 91. 3%). Figure 13: Treatment success rate in culture-confirmed new pulmonary TB cases notified in 2011, by country, EU/EEA, 2012 Treatment success (%) 100 80 60 40 20 EU /E E Au A st r Be ia lg iu Bu m lg ar ia Cz C ec yp h r Re us pu De blic nm ar Es k to n Fi ia nl a Ge nd rm a Hu ny ng ar Ir y el an d La Li tvia th ua ni a Ne Ma th lta er la nd No s rw a Po y la Po nd rtu Ro gal m an Sl ia ov ak Sl ia ov en ia Sp a Un S in ite we d d Ki en ng do m 0 * Iceland Malta reported zero new TB cases in 2011. Three EU/EEA Member States did not report treatment outcome data 14

Treatment success in previously treated pulmonary TB cases The treatment success rate for previously

Treatment success in previously treated pulmonary TB cases The treatment success rate for previously treated culture-confirmed pulmonary TB cases notified in 2011 was 55. 2% (range 25. 0– 100. 0%). Figure 14: Treatment success rate in previously treated culture-confirmed pulmonary TB cases notified in 2011, by country, EU/EEA % Treatment success (%) 100 80 60 40 20 ve ni ia ak Sl o ia Sl ov l m an ga Ro rtu nd Po la ay Po No rw nd s a Sp ai n Sw Un ite ed en d Ki ng do m Ne th er la ni a ia ua Li th tv d La el an y Ir ng ar an y Hu m nd la Ge r k ni a Fi n to ar Es lic De nm s pu b Re pr u Cy h ec m Bu l lg iu ria Be st Au ga ria Cz Su b to ta l. E U/ EE A 0 * Iceland Malta reported zero previously treated TB cases in 2011. Three EU/EEA Member States did not report treatment outcome data stratified by treatment history 15

Treatment success rate in confirmed pulmonary TB cases* The treatment success rate for all

Treatment success rate in confirmed pulmonary TB cases* The treatment success rate for all confirmed pulmonary TB cases notified in 2011 was 72. 4% (range 0– 90. 4%). Figure 15: Treatment success rate in laboratory confirmed pulmonary TB cases notified in 2011, by country, EU/EEA, 2012 Treatment success (%) 100 80 60 40 20 EU /E E Au A st Be ria lg iu Bu m lg ar ia Cz C ec yp h Re rus pu De blic nm ar Es k to n Fi ia nl Ge and rm a Hu ny ng ar Ir y el an d La Li tvia t Lu hua xe n m ia bo ur g Ne Ma th lta er la n No ds rw a Po y la Po nd rtu Ro gal m an Sl ia ov a Sl kia ov en ia Sp ai Un n ite Swe d de Ki ng n do m 0 * Four EU/EEA Member States did not report treatment outcome data 16

Treatment success rate in extrapulmonary TB* The treatment success rate in extrapulmonary TB cases

Treatment success rate in extrapulmonary TB* The treatment success rate in extrapulmonary TB cases notified in 2011 was 82. 2% (range 59. 0– 100%). Figure 16: Treatment success rate in extrapulmonary TB cases notified in 2011, by country, EU/EEA, 2012 Treatment success (%) 100 80 60 40 20 EU /E EA Au st r Be ia lg iu Bu m lg ar ia Cz ec Cyp h r Re us pu De blic nm ar Es k to Ge nia rm a Hu ny ng ar Ic y el an Ir d el an d La t Li via th ua ni a Ne Ma th lta er la nd No s rw ay Po la Po nd rtu Ro gal m an Sl ia ov ak Sl ia ov en ia Sp a Un S in ite we d d Ki en ng do m 0 * Five Member States did not report stratified treatment outcome data 17

Treatment success rate in multidrug-resistant TB* The treatment success rate for all multidrug-resistant TB

Treatment success rate in multidrug-resistant TB* The treatment success rate for all multidrug-resistant TB cases notified in 2010 was 33. 6% (range 0– 100. 0%). Figure 17: 24 -month treatment success rate in multidrug-resistant TB cases notified in 2010, by country, EU/EEA, 2012 Treatment success (%) 100 80 60 40 20 EU /E EA Au st ri Be a lg iu m B ul Cz ga ec r h Re ia pu b De lic nm ar k Es to n Ge ia rm an Hu y ng ar y Ir el an d La tv ia Li th ua ni a M a Ne th lta er la nd s No rw ay Po la n Po d rtu g Ro al m an ia Sl ov ak ia Sw Un ed ite en d Ki ng do m 0 * Slovenia reported zero MDR TB cases in 2010, 9 Member States did not report treatment outcome data for MDR TB cases 18

Treatment outcome in multidrug-resistant TB over time Treatment outcomes for multidrug-resistant TB cases improved

Treatment outcome in multidrug-resistant TB over time Treatment outcomes for multidrug-resistant TB cases improved slightly between the 2008 and 2010 cohort, EU/EEA. Figure 18: 24 -month treatment outcome in multidrug-resistant TB cases notified from 2008 to 2010, by year of initial case reporting, EU/EEA, 2012 40 Treatment success (%) cohort 2008 cohort 2009 30 cohort 2010 20 10 0 Success Died Failed Defaulted Still on treatment Transferred or unknown 19

Treatment success in extensively drug-resistant TB* The treatment success rate in extensively drug-resistant TB

Treatment success in extensively drug-resistant TB* The treatment success rate in extensively drug-resistant TB cases notified in 2009 was 25. 0% (range 0– 66. 7%). Figure 19: 36 -month treatment success rate in extensively drug-resistant TB cases notified in 2009, by country, EU/EEA, 2012 Treatment success (%) 80 60 40 20 0 EU/EEA Austria Belgium Bulgaria Czech Republic Estonia Latvia Lithuania Norway Poland Romania United Kingdom * Cyprus, Denmark, Iceland, Malta, Slovakia, Slovenia and Sweden reported zero XDR TB cases in 2009, 12 countries did not report SLD DST results or stratified treatment outcome data 20